26 /100
MEDIUM RISK
Score updated May 30, 2026

ANRO — Alto Neuroscience, Inc. Dilution Risk Tracker

Track ANRO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANRO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
14%
💰 Capital Raise 20%
• Active shelf registration ($120M, 17% of market cap)
📉 Score Deterioration 15%
• Score climbed 5 points (worsening)
🔔 Track ANRO — Get forecast alerts →

💹 Market Data

Market Cap$704.34M
Shares Outstanding35.09M
Float23.95M
Cash$263.76M
Debt$21.91M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 46.7% shares (2025Q4 vs prior)
97 institutional holders · 25.14M shares
#1 Alpha Wave Global, LP 3.71M shares
#2 Vestal Point Capital, LP 2.48M shares
#3 Commodore Capital LP 1.82M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.61M
Days to Cover4.7
% of Float6.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
EFFECT EFFECT Apr 20, 2026
S-3 SHELF Apr 10, 2026
8-K 8K EVENT Mar 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ANRO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANRO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ANRO
📊 ANRO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ANRO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.